Unichem Laboratories' Stock Soars, Outperforms Sector and Sensex with Impressive Gains

Oct 11 2024 03:45 PM IST
share
Share Via
Unichem Laboratories, a midcap pharmaceutical company, has been performing exceptionally well in the stock market. On October 11, 2024, its stock gained 6.76%, outperforming the sector by 5.58%. This trend has been consistent for the past two days, with the stock rising by 11.93%. The company has also hit a new 52-week and all-time high, indicating strong potential for growth. Unichem Laboratories has outperformed the Sensex in both short and long-term periods, making it a promising investment option in the midcap segment.

Unichem Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On October 11, 2024, the company's stock gained 6.76%, outperforming the sector by 5.58%. This positive trend has been consistent for the past two days, with the stock rising by 11.93% in that period.

The stock's performance has been so impressive that MarketsMOJO has given it a 'Buy' call. Unichem Laboratories has also hit a new 52-week and all-time high of Rs.717.7, which was achieved today. This is a significant milestone for the company and shows its strong potential for growth.

In terms of moving averages, Unichem Laboratories is trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates a positive trend and further reinforces the company's strong performance.

When compared to the Sensex, Unichem Laboratories has outperformed with a 6.76% gain in just one day, while the Sensex only saw a -0.28% change. In the past month, the company's stock has also outperformed the Sensex with a 20.98% gain, while the Sensex only saw a -0.17% change.

Unichem Laboratories' success in the stock market is a testament to its strong position in the pharmaceutical industry. With its recent gains and positive outlook, the company is definitely one to watch out for in the midcap segment. Investors can consider adding Unichem Laboratories to their portfolio for potential growth and returns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News